������ý

Foley partner Kyle Faget, co-chair of the firm’s Medical Devices Area of Focus, is speaking in American Conference Institute’s Inaugural Summit on GLP-1 Law & Policy on July 24.

Foley partners Monica Chmielewski, vice chair of the firm’s Health Care Practice Group, Kyle Faget, and Nate Beaver, co-chairs of the firm’s Medical Devices Area of Focus, are speaking at Dynamic Global Events’ 6th Clinical Trial Agreements (CTA) Summit on August 21-22.

Securities Enforcement Forum West is a unique, one-day conference that brings together hundreds of current and former senior SEC officials, securities enforcement and white-collar attorneys, in-house counsel and compliance executives, and other top professionals in the field.

With the size and scope of President Trump’s tariffs continuing to shift, this is a critical time for businesses to assess their contracts and determine how increased tariff costs might adversely affect profitability, and whether there are any strategies to mitigate the losses.

The case, United States v. Sorenson, addressed whether a Medicare-registered distributor violated the AKS in making payments to advertising, marketing, and manufacturing companies that worked to sell orthopedic braces to Medicare patients. The court held that such payments were not “referrals” within the meaning of the AKS because the payments were made to entities that were neither physicians in a position to refer their patients nor other decisionmakers in positions to “leverage fluid, informal power and influence” over health care decisions.

On April 17, 2025, the Centers for Medicare and Medicaid Services (CMS) announced another extension of the deadline by which skilled nursing facilities (SNFs) must revalidate their Medicare enrollments.

This episode of The Path & The Practice features a conversation with David Goroff. David is a litigation partner in Foley’s Chicago office where he is also chair of Foley’s appellate practice group.

This episode of The Path & The Practice features a conversation with William McKenna. Bill is a litigation partner in Foley’s Chicago office.

This episode of The Path & The Practice features a conversation with Andrew Wronski. Andy is a litigation partner in Foley’s Milwaukee office where he is also the office managing partner.

Since 2018, licensing deals totaling over $60 billion have been signed regarding Antibody Drug Conjugates (ADCs), with 2023 alone having at least 18 deals.

As we make further strides into 2024, the fashion, apparel & beauty landscape continues its dynamic evolution, marked by opportunities and challenges.

������ý; Lardner’s 2024 Health Care & Life Sciences Top Trends publication unpacks fast-moving developments to help your business.

Employers may now be looking for ways to manage the impending financial impact on their business, including trying to lower HR-related costs and obligations through reducing or suspending employer retirement plan contributions.   This article considers several questions employers may be asking about ways to reduce corresponding costs with respect to employer-sponsored qualified retirement plans, like 401(k), 403(b), and pension plans.

Many companies are scrambling to quickly assess how to reduce the business impact of the upheaval to U.S. manufacturing and trading with the recent onslaught of tariffs threatened or imposed by the United States and the related global response.

The U.S. Supreme Court has broadened plaintiffs’ ability to sue under the Racketeer Influenced and Corrupt Organizations Act (RICO) for economic loss stemming from personal injury.